Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Clinical trial NCT06597019 · RECRUITING
Trial details
- NCT number
- NCT06597019
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2028-03-21
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.